By: Syed Abuzer -- Senior Research Analyst
28 March, 2013
Conventionally, pharmaceutical organizations make use of air freight and trucking for their transportation requirements and around 5% of their volume is moved through ocean freight. However, in recent times companies have considered shifting a part of their volumes on specific trade lanes to ocean freight (through reefer containers).
This white paper would address the possible cost benefits involved in utilizing ocean freight, also covering any prior case of a Pharmaceutical organization that has been successful in the transition and analyzing the results of the same.
COVID-19: Assess impact on your suppliers and ensure business continuity with Beroe’s WIRE
(World Instant Risk Exposure)